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ABSTRACT 
Ayurveda has its own way of processing herbal, mineral, metallic and animal origin materials to 
prepare therapeutic dosage forms. Pharmacology is the science of drugs including their origin, 
composition, pharmacokinetics, therapeutic use, and toxicology.  Pharmacology is the base of 
research and development in all medical sciences which utilizes natural or synthetic materials for 
therapeutic purposes and such materials as known as medicines. Importance of 
Pharmacokinetics in Ayurveda: It is evident that understanding of pharmacokinetic 
characteristic especially bioavailability of Ayurveda drug compounds is needed while planning as 
well as interpreting the result of experimental/clinical studies. Challenges to Herbo-mineral 
compounds: Several experiments as well as clinical researches regarding safety profile of 
Rasoushadhi have been conducted at various Ayurveda institutes at graduate and post graduate 
level, however these researches have not attracted the attention on global platform. Conclusion: 
Pharmacokinetic studies will be helpful in discovery of Ayurveda drug action, organ involved, 
safety studies, dose determination, ADME of AYUSH medicines, information of bioavailability, 
mode of action, identifing differences in Ayurveda drugs having similar chemical composition. 
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INTRODUCTION 
India is one of the 12 mega biodiversity zone 
covering 2.4% of world’s area but with 8% of global 
biodiversity. It includes 15 agro-climatic zones 
containing about 47,000 plant species including 
nearly 15,000 medicinal plants[1]. Experimentation is 
the stepping stone for the advancement of science. 
Over the last 25 years, Pharmacokinetics has 
emerged as an integral part of drug development 
especially when identifying a drug’s biological 
properties. The term thereby implies the time course 
and fate of drug in the body. Bio availability captures 
two essential features, namely how fast does the drug 
enter the systemic circulation (rate of absorption) 
and how much of the nominal strength enters the 
body (extend of absorption). Given that the 
therapeutic effect is a function of the drug 
concentration, the above properties of non 
intravenous dosage forms are there for important in 
identifying the response to a drug dose[2]. Bio 
availability following oral doses may vary due to 
patient related or dosage form related factors. The 
dosage form related factors include the chemical 
form of the drug, its physical properties and 
manufacturing variables. Generally herbomineral 
formulations are multi component mixtures, 
containing plant and animal– derived products, 
minerals and metals. Ancient’s texts like ‘Rig Veda’, 
Atharva Veda, and Official compendia like Ayurvedic 
Pharmacopoeia, Ayurvedic Formulary show 
dominance of plant and mineral derived products.[3] 
More than 25000 single or poly herbal formulations 
are used by the tribal and rural population in India[4]. 
Export – Imports bank reports reveals that the global 
trade of plant derived and plant originated products 
is of around US $62 billion (with growth of 7% per 
annum) where India holds stake US $1billion.[5] 
There is an urgent need to cherish these in both the 
national and international perspectives for benefit of 
mankind. Apart from healthcare, medicinal plant 
trade is an important alternative income generating 
source for under-privileged communities. As far as 
Ayurvedic formulations are concerned the concept of 
drug action and absorption is designed on the basis 
of the Panchamahabhuta theory, Agni, Rasa, Guna, 
Virya, Vipaka etc of the drug. Pharmacokinetics 
studies supports the studies of preclinical toxicology 
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in animals (toxicokinetics) because the drug levels in 
plasma or tissues are often more predictive than the 
dose to extrapolate the toxicity data to man. To go for 
the bio availability of the Ayurvedic formulations 
especially Herbo minerals is a daunting task but they 
provide strong evidence base to the safety and 
efficacy of herbo mineral formulations. 
International market scenario of Indian 
medicinal plants 
Global market of herbal industry shares about 
US $62 Billion.[6] The value of botanical related trade 
in India is about US $10 billion per annum with 
annual export of US $1.1 billion[7] while China’s 
annual herb drug production is worth US $48 billion 
with export of US $3.6 billion[8]. India seems to be 
lagging behind and is ranked third in the herbal 
medicine category, with less than 2% global market 
share. According to an Ayurveda expert, Chinese 
herbal medicines, which rarely contain 10% scientific 
base when compared with the Indian Ayurvedic 
system, are doing better than India by 50-fold[9,10]. 
India had failed to make an impact in the global share 
market with Ayurvedic system of medicine and the 
gap between Indian and other countries is extending 
rapidly in the herbomineral field. The export of 
herbal medicine from India is insignificant despite 
the fact that country has a rich traditional knowledge 
and heritage of herbal medicine. The constant 
challenges for herbomineral medicine are lack of 
standardization, quality control and pharmacokinetic 
profile of bioactive molecules. Although the 
herbalmineral medicines have been used for 
thousands of years, basic research programmers 
need to be focused on the quality assurance. To 
overcome contaminations from pesticide residues 
and heavy metals there should be a control measures 
to implement necessary Standard Operating 
Procedures (SOP) at source. Good laboratory 
practices (GLP), Good Agricultural practices (GAP) 
and Good Manufacturing practices (GMP) are needed 
to produce good quality medicinal products. Also 
scientific based complete pharmacological data is 
required for the Ayurvedic system of medicine. 
Without all these measures, it is impossible to realize 
the dream of having a major share of herbal drug 
industry despite having goldmine of well 
documented and well-practiced knowledge of 
traditional herbal medicines. Both India and China 
having great traditional systems of medicines with 
strong philosophical basis and could play an 
important role in new therapies, drug discovery and 
development process.[11]  
Challenges to Herbomineral Compounds 
Although herbomineral medicines are widely 
used for the prevention, diagnosis, treatment and 
management of diseases, quality control and proper 
regulation worldwide are still a big challenge as 
shown in Figure 1. Widespread and growing use of 
botanicals has created a global challenge in terms of 
quality, safety and efficacy. Scientific validation and 
standardization of herbal medicines is needed for the 
future advancement of traditional medicine. Proper 
use of products of assured quality could also do much 
to reduce any risks associated with herbal medicine. 
However, regulation and legislation of herbal 
medicines has been enacted in very few countries. 
Most of the countries do not have any proper 
regulation on botanicals and the quality of herbal 
products sold is generally not guaranteed. [12,13].  
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Figure 1: Constant challenges for Herbo-mineral medicine 
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Establishing the pharmacological basis of efficacy of 
herbomineral products is constant challenge due to 
their complex composition and the ever-increasing 
list of their putatively active constituents. In vitro 
assays normally are cheap and relatively easy to 
perform, but the relevance of the findings is based on 
a sufficient concentration of active constituents at the 
site of action. Of particular interest is the question of 
bioavailability to assess to what degree and how fast 
compounds are absorbed after oral administration of 
herbo-mineral products. Of further interest are the 
elucidation of metabolic pathways which yields 
potentially new active compounds and the 
assessment of elimination route and their kinetics. 
Thus the pharmacokinetic data will become an 
important link data from pharmacological assays and 
clinical effects.  
There is usually detailed information 
available about the pharmacokinetics and bio 
pharmaceutics of chemical active pharmaceutical 
ingredients but it is absolutely lacking in the case of 
herbo-mineral medicine. The reason for that lies in 
the complexity of extracts as multi component 
mixtures and lack of knowledge of the active 
principles. With increasing knowledge of putatively 
active compounds and availability of highly selective 
and sensitive analytical methods pharmacokinetics 
can be evaluated for the Herbo-mineral formulations.  
Pharmacokinetics: A missing critical step in the 
Validatation of Herbo-mineral medicine 
Pharmacokinetics of the new drug entity is 
one of the regulatory requirements for an 
investigational new drug approval. However, for the 
majority of Herbo-mineral formulations used in the 
traditional or conventional medical practice, data on 
their disposition and biological fate in human are 
lacking. It is vital in the drug development process to 
understand the absorption, distribution, metabolism 
and excretion (ADME) of an active molecule from 
these formulations and how they interact with 
conventional drugs before their launch in the market 
in order to ensure the rational use of herbo-mineral 
medicines. Pharmacokinetics in the Ayurvedic system 
are largely ignored due to the rigor, cost and time 
consumption of the drug development process. One 
of the major reasons is that for most of these multi 
component mixtures their active ingredients are not 
known. In addition, there is a difficulty of measuring 
the quantities of the active constituents in systemic 
circulations due to very low concentrations, arising 
from the very small amount per dose in the final 
product. These challenges have led to the situation 
that most herb-drug interaction studies and case 
reports in the literature only evaluate the outcome of 
adding an herbal product to an existing conventional 
drug therapy and monitoring changes in 
pharmacokinetics and clinical response on the 
traditional drug[14]. The metabolism of a drug can be 
altered by another drug or foreign chemical; such 
interactions are significant in clinical effects. 
Cytochrome P450 enzymes, a super family of 
enzymes found mainly in the liver are involved in 
numerous interactions between drugs food, herbs 
and other drugs. The observed induction and 
inhibition of the CYP enzymes by natural products in 
the presence of prescribed drug has led to the 
general acceptance that natural therapies can have 
adverse effects contrary to the popular beliefs in 
countries where there is an active practice of 
traditional medicine. Majority of the classes of 
conventional drugs have been shown to be affected 
by different types of herbo-mineral preparations 
leading to various consequences, including treatment 
failure, adverse / toxic effects and even death. In 
order to improve the safety of Herbo-mineral 
medicine, use alongside conventional therapies in 
public healthcare, it is necessary to know that how 
the herbal drugs interact with conventional drug, 
early in the drug development. It is also necessary to 
predict early so as to eliminate regulatory obstacles 
and avoid market pressure for recalls that may have 
been induced by adverse effects linked to 
interactions. Therefore a better understanding of the 
pharmacokinetics of Herbo-mineral formulations is 
needed to support the predictability of herb– mineral 
interactions. 
Non-compartmental approach to 
pharmacokinetic analysis of Herbo-mineral 
formulations 
Theoretically when the drug is rapidly 
distributed to all parts of the body, the body behaves 
as one compartment and the drug profile in the body 
can be described as one compartment 
pharmacokinetic model. On the other hand when the 
distribution of the drug in a group of tissues or 
organs is faster than its distribution to other tissues 
or organs, the body behaves as two different 
compartments and the drug profile in the body can 
be described by a two compartment pharmacokinetic 
model. The body can also behaves as multiple 
compartments when the drug is distributed to 
different group of tissues at different rates. The 
compartmental approach in data analysis sometimes 
is faced with some difficulties such as when the drug 
concentration-time profile after intravenous 
administration is described by a two compartment 
pharmacokinetic model, but after oral administration 
of the same drug, the profile is similar to that of the 
one compartmental model because the rate of 
absorption and distribution process are not 
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distinctively different. To avoid these difficulties, a 
different approach, known as the non-compartmental 
approach, may be used for data analysis which can be 
examined without the need to assume a certain 
compartmental model[15]. The non-compartmental 
approach in pharmacokinetic data analysis is based 
on the statistical moment theory, which has been 
utilizes in chemical engineering. This theory views 
the drug molecules in the body as randomly 
distributed and each molecule has certain probability 
to be eliminated at certain time t. So, according to this 
theory, the time course for the drug concentration in 
plasma can be regarded as probability density 
function. This probability density function multiplied 
by time raised to certain power (0, 1 or 2) and 
integrated over time yields the area under the 
moment curve.  
Mean residence time 
The drug molecules are distributed 
throughout the body after drug administration. Some 
drug molecules are eliminated from the body faster 
than other molecules, which stay longer despite the 
fact that all the molecules are similar. The difference 
in the residence time for each molecule in the body 
occurs by chance according to statistical moment 
theory. The MRT is defined as the average time for 
the residence of all the drug molecules in the body. 
MRT can be calculated from the area under zero and 
first moment curve according to equation. 
𝑀𝑅𝑇 =
𝐴𝑈𝑀𝐶
𝐴𝑈𝐶
 
Where AUMC is the area under the first moment – 
time curve and AUC is the area under the zero 
moment time curve or the area under the plasma 
concentration-time curve. The MRT has units of time. 
The absolute bioavailability is determined from the 
ratio of AUC after oral and IV administration as in 
equation. 
𝐹
 𝐴𝑏𝑠𝑜𝑙𝑢𝑡𝑒  = 
𝐴𝑈𝐶𝑂𝑟𝑎𝑙
𝐴𝑈𝐶 𝑖𝑣
 
and the relative bioavailability of two products is 
determined from the ratio of AUC for the two 
different oral products as in the equation. 
𝐹
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒  =
𝐴𝑈𝐶𝑃𝑟𝑜𝑑𝑢𝑐𝑡  𝐴
𝐴𝑈𝐶𝑃𝑟𝑜𝑑𝑢𝑐𝑡  𝐵
 
CONCLUSION 
Recognition of the medical and health 
benefits of Herbo-mineral medicine with health 
claims is growing worldwide. Pharmaceutical 
research must go beyond focusing on 
pharmacological efficacy of Herbo-mineral 
formulations mainly in studies that improves their 
effectiveness in order to fully benefit humanity from 
their inherent therapeutic potentials. With advance 
in instrumentation like AAS and ICP-MS as increasing 
number of components are being identified from 
starting material used for preparation of those 
products. India needs a clear policy for such 
integration without compromise on the strategies 
that are science based. Efforts are needed to establish 
and validate pharmaco-epidemiological evidence 
regarding safety and practice of Herbo-mineral 
medicines. Pharmacokinetic data of biomarkers 
contribute considerably to the scientific assessment 
of the various claims of herbo-mineral products, 
which are increasingly marketed with curative claims 
worldwide. While a registration process reviewing 
quality, safety and efficacy of herbo-mineral products 
is established in curtained European countries and 
also the FDA is considering to review certain 
botanicals via the IND/NDA (Investigational New 
Drug/New Drug Application) process. In summary 
Indian alchemial preparations having great 
traditional with strong philosophical basis and could 
play an important role in new therapies, drug 
discovery and development process. Herbo-mineral 
system of medicine with strong scientific evidence 
will be top leader in the global market. 
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